Dencichine ameliorates hepatic fibrosis by modulating the PI3K/AKT signaling pathway in cellular and murine models.

Li L, Mo L, Luo H, Liu Z, Zhang W, Tian J, Meng F, Chen Y

Open source

DOI
10.36721/pjps/2026.40.16394.1
Published
2027 Jan 1
Container
Pakistan journal of pharmaceutical sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36721/pjps/2026.40.16394.1,
  title = {Dencichine ameliorates hepatic fibrosis by modulating the PI3K/AKT signaling pathway in cellular and murine models.},
  author = {Li L and Mo L and Luo H and Liu Z and Zhang W and Tian J and Meng F and Chen Y},
  year = {2027},
  journal = {Pakistan journal of pharmaceutical sciences},
  doi = {10.36721/pjps/2026.40.16394.1},
  url = {https://doi.org/10.36721/pjps/2026.40.16394.1}
}

RIS

TY  - JOUR
TI  - Dencichine ameliorates hepatic fibrosis by modulating the PI3K/AKT signaling pathway in cellular and murine models.
AU  - Li L
AU  - Mo L
AU  - Luo H
AU  - Liu Z
AU  - Zhang W
AU  - Tian J
AU  - Meng F
AU  - Chen Y
PY  - 2027
JO  - Pakistan journal of pharmaceutical sciences
DO  - 10.36721/pjps/2026.40.16394.1
UR  - https://doi.org/10.36721/pjps/2026.40.16394.1
ER  - 

APA

L, L., L, M., H, L., Z, L., W, Z., J, T., F, M., & Y, C. (2027). Dencichine ameliorates hepatic fibrosis by modulating the PI3K/AKT signaling pathway in cellular and murine models.. Pakistan journal of pharmaceutical sciences. https://doi.org/10.36721/pjps/2026.40.16394.1

Source records